High Blood caffeine levels in MCI linked to lack of progression to dementia.
about
Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors.Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cellsThe role of ryanodine receptor type 3 in a mouse model of Alzheimer diseaseGas chromatography time-of-flight mass spectrometry (GC-TOF-MS)-based metabolomics for comparison of caffeinated and decaffeinated coffee and its implications for Alzheimer's disease.Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Caffeine inhibits glucose transport by binding at the GLUT1 nucleotide-binding site.From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?The influence of roasting and additional processing on the content of bioactive components in special purpose coffees.Lifestyle Factors and Dementia in the Oldest-old: The 90+ Study.Inconsistency of Association between Coffee Consumption and Cognitive Function in Adults and Elderly in a Cross-Sectional Study (ELSA-Brasil)Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study.Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation.Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.Associations between Lifestyle Factors and Parkinson's Disease in an Urban Sri Lankan Clinic Study.Istradefylline reduces memory deficits in aging mice with amyloid pathology.Long-term Treatment with Low-Dose Caffeine Worsens BPSD-Like Profile in 3xTg-AD Mice Model of Alzheimer's Disease and Affects Mice with Normal Aging.
P2860
Q27343149-55E1F9ED-36D6-449C-B28A-421695184781Q28385402-48C0DC7C-B5D2-41AB-ACD7-B95F8534282AQ30594530-70362E61-BEAE-4169-9962-8D7CAAFF029DQ34011240-B64893C0-B318-4DFE-8FE4-03E271AFF8ABQ34540333-973664C6-A7E9-434A-B161-901074566D1BQ35622435-F341D4C4-2920-4BB3-90D3-42C2ACC9113FQ35634105-ECABC83C-958C-4407-8A22-8AD3AC193A73Q36010939-5EABE624-E100-486F-9E7D-366679936191Q36031659-F1437412-C668-46A7-BBD1-D11F34F31CD3Q36329946-39C32EC1-FE03-4310-81CB-D1513B686C2FQ36334362-2FAF2FB6-DB44-4433-8EAA-C619FD1AC42EQ38109630-0F6EE514-4298-4258-8F3A-46ECF9E86EEBQ40563346-8569F726-273A-48B0-B69A-76B956678703Q42269908-69C5DE02-FD8A-4E59-ACAE-71F7C1CF1043Q42412786-B10B5CF4-0137-488F-B9B4-528774565E16Q47104552-EA909AE1-B17E-4165-8007-566071664F3FQ47443548-BEFEFD09-B74A-4664-A702-3B14103F06E9Q50421252-5A1B8896-5B8A-475E-B67A-6C3766E9C67D
P2860
High Blood caffeine levels in MCI linked to lack of progression to dementia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
High Blood caffeine levels in MCI linked to lack of progression to dementia.
@en
type
label
High Blood caffeine levels in MCI linked to lack of progression to dementia.
@en
prefLabel
High Blood caffeine levels in MCI linked to lack of progression to dementia.
@en
P2093
P2860
P356
P1476
High Blood caffeine levels in MCI linked to lack of progression to dementia.
@en
P2093
Alessandra Giannini
Brent Small
Chuanhai Cao
David A Loewenstein
Elizabeth Schofield
Gary W Arendash
Huntington Potter
Jianfeng Cai
P2860
P304
P356
10.3233/JAD-2012-111781
P50
P577
2012-01-01T00:00:00Z